Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,333 | 44,068 | 35,777 | 28,202 | 24,427 |
| Receivables | 18,737 | 21,463 | 17,308 | 14,820 | 11,779 |
| Inventories | 10,997 | 8,284 | 7,303 | 8,950 | 8,547 |
| Income taxes - deferred | 659 | 2,032 | 1,919 | 1,991 | 2,184 |
| TOTAL | $94,592 | $77,385 | $64,138 | $56,322 | $49,830 |
| Non-Current Assets | |||||
| PPE Net | 32,939 | 35,113 | 36,470 | 36,981 | 35,748 |
| Intangibles | 28,442 | 29,401 | 32,032 | 34,856 | 39,935 |
| Other Non-Current Assets | 69 | 171 | 205 | 777 | 3,920 |
| TOTAL | $61,450 | $64,685 | $68,707 | $72,615 | $79,602 |
| Total Assets | $156,042 | $142,069 | $132,844 | $128,937 | $129,431 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,600 | 1,600 | 1,600 | 1,600 |
| Accounts payable and accrued liabilities | 2,794 | 2,342 | 4,300 | 9,694 | 6,355 |
| Accrued Expenses | 5,538 | 5,837 | 5,322 | 5,376 | 5,816 |
| TOTAL | $9,283 | $14,453 | $14,538 | $19,370 | $16,522 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 8,000 | 9,600 | 11,200 | 12,800 |
| Deferred Revenues | 180 | 2,875 | 2,867 | 2,700 | 2,752 |
| Other Non-Current Liabilities | 1,134 | 1,541 | 1,549 | 1,560 | 1,775 |
| TOTAL | $11,125 | $18,691 | $23,543 | $24,377 | $30,766 |
| Total Liabilities | $20,408 | $33,144 | $38,082 | $43,747 | $47,288 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,325 | 13,919 | 13,669 | 13,458 | 13,449 |
| Common Shares | 143 | 139 | 136 | 135 | 134 |
| Retained earnings | 66,584 | 46,010 | 34,252 | 25,786 | 21,470 |
| Other shareholders' equity | -1,699 | -2,655 | -3,067 | -2,548 | 0 |
| TOTAL | $135,634 | $108,925 | $94,763 | $85,190 | $82,144 |
| Total Liabilities And Equity | $156,042 | $142,069 | $132,845 | $128,937 | $129,431 |